A global Contract Research Organization (CRO) with over 30 years of experience, CMIC’s skilled researchers provide cutting-edge expertise in small and large molecule bioanalysis to optimize drug development for pharmaceutical companies. We offer bioanalysis for non-clinical and clinical projects, both GLP and non-GLP, to meet critical drug development milestones. CMIC's GLP compliant state-of-the-art facility has the capacity to accommodate quick turnaround and high-volume projects from around the country.